Conventional radiotherapy and intensity-modulated radiotherapy in carcinoma vulva: An experience from a tertiary medical center of India

被引:10
作者
Mazumder, Koustav [1 ]
Elangovan, Arun [1 ]
Rai, Bhavana [1 ]
Suri, Vanita [2 ]
Jain, Vanita [2 ]
Kalra, Jaswinder [2 ]
Ghoshal, Sushmita [1 ]
机构
[1] Postgrad Med Educ & Res, Dept Radiotherapy & Oncol, Chandigarh, India
[2] Postgrad Med Educ & Res, Dept Gynecol & Obstet, Chandigarh, India
关键词
Radiotherapy; cancer; vulva; DOSIMETRIC EVALUATION; CANCER;
D O I
10.4103/sajc.sajc_66_17
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Context: Vulvar cancer is one of the uncommon gynecological malignancies. Multimodality treatment with surgery, radiotherapy, and chemotherapy are required for treatment of the disease. Aims: The aim of the study was to evaluate clinical outcome in patients of carcinoma vulva, treated at our institution. Subjects and Methods: This was a retrospective-cohort study done in 50 patients with squamous cell carcinoma of the vulva, treated at our institution from January 2008 to December 2014. Data were analyzed on the basis of age, stage, type of treatment received, and treatment-related toxicity. Disease-free survival and overall survival were estimated. Statistical Analysis Used: Kaplan-Meier survival analysis and Chi-square test were used for statistical analysis. Results: Majority of the patients (52%) had presented with Stage III disease. Thirty-six of 50 patients underwent surgery: simple vulvectomy - 2, radical vulvectomy - 34, bilateral inguinal lymph node dissection was done in 32 patients, and 1 patient underwent ipsilateral-inguinal lymph node dissection. Among 40 patients who received radiotherapy and eight patients received palliative radiotherapy. Seventeen patients underwent intensity-modulated radiotherapy (IMRT) and 15 patients received conventional radiotherapy. Significantly less Grade 2 or more skin toxicity (P = 0.003) observed in patients who underwent IMRT. Among non-IMRT group, eight patients required treatment break during radiation. At a median follow-up time of 25.5 months, median overall survival was 31 months and median disease-free survival was 25 months. About 42% patients were alive and free of disease at last follow-up. Conclusions: Modified radical vulvectomy with inguinal lymph node dissection followed by radiotherapy is the mainstay of management of locally advanced carcinoma vulva. Using IMRT, we could minimize the treatment related radiation toxicity and treatment breaks.
引用
收藏
页码:41 / 43
页数:3
相关论文
共 50 条
  • [21] Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy
    Kuo, Yu-Cheng
    Chiu, Ying-Ming
    Shih, Wen-Pin
    Yu, Hsiao-Wei
    Chen, Chia-Wen
    Wong, Pei-Fong
    Lin, Wei-Chan
    Hwang, Jeng-Jong
    RADIATION ONCOLOGY, 2011, 6
  • [22] Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma
    Abelson, Jonathan A.
    Murphy, James D.
    Minn, Ann Yuriko
    Chung, Melody
    Fisher, George A.
    Ford, James M.
    Kunz, Pamela
    Norton, Jeffrey A.
    Visser, Brendan C.
    Poultsides, George A.
    Koong, Albert C.
    Chang, Daniel T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (04): : E595 - E601
  • [23] Intensity-modulated radiotherapy for elderly patients with nasopharyngeal carcinoma
    Cao, Caineng
    Hu, Qiaoying
    Chen, Xiaozhong
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (03): : 590 - 595
  • [24] Intensity-Modulated Radiotherapy for Oropharyngeal Squamous Cell Carcinoma
    Mendenhall, William M.
    Amdur, Robert J.
    Morris, Christopher G.
    Kirwan, Jessica M.
    Li, Jonathan G.
    LARYNGOSCOPE, 2010, 120 (11) : 2218 - 2222
  • [25] Patterns of failure in anaplastic and differentiated thyroid carcinoma treated with intensity-modulated radiotherapy
    Vulpe, H.
    Kwan, J. Y. Y.
    McNiven, A.
    Brierley, J. D.
    Tsang, R.
    Chan, B.
    Goldstein, D. P.
    Le, L. W.
    Hope, A.
    Giuliani, M.
    CURRENT ONCOLOGY, 2017, 24 (03) : E226 - E232
  • [26] Clinical outcome of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy in locally advanced nasopharyngeal carcinoma: Comparative study at SKIMS Tertiary Care Institute
    Fatima, Kaneez
    Andleeb, Asifa
    Sofi, Mushtaq Ahmad
    Rasool, Malik
    Fir, Afroz
    Nasreen, Shahida
    Dar, Nazir Ahmad
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (01) : 133 - 139
  • [27] Comparison of conventional radiotherapy and intensity-modulated radiotherapy for post-operative radiotherapy for primary extremity soft tissue sarcoma
    Stewart, Alexandra J.
    Lee, Young K.
    Saran, Frank H.
    RADIOTHERAPY AND ONCOLOGY, 2009, 93 (01) : 125 - 130
  • [28] Effects of Intensity-modulated Radiotherapy on Human Oral Microflora
    Shao, Zi-Yang
    Tang, Zi-Sheng
    Yan, Chao
    Jiang, Yun-Tao
    Ma, Rui
    Liu, Zheng
    Huang, Zheng-Wei
    JOURNAL OF RADIATION RESEARCH, 2011, 52 (06) : 834 - 839
  • [29] Paclitaxel and cisplatin combined with intensity-modulated radiotherapy for upper esophageal carcinoma
    Tu, Lingli
    Sun, Lan
    Xu, Yong
    Wang, Yongsheng
    Zhou, Lin
    Liu, Yongmei
    Zhu, Jiang
    Peng, Feng
    Wei, Yuquan
    Gong, Youling
    RADIATION ONCOLOGY, 2013, 8
  • [30] Paranasal Sinus Invasion in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy
    Cao, Caineng
    Jiang, Feng
    Jin, Qifeng
    Jin, Ting
    Huang, Shuang
    Hu, Qiaoying
    Chen, Yuanyuan
    Piao, Yongfeng
    Hua, Yonghong
    Feng, Xinglai
    Chen, Xiaozhong
    CANCER RESEARCH AND TREATMENT, 2019, 51 (01): : 73 - 79